NKG2D ligands in tumor immunity
- 6 October 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 27 (45), 5944-5958
- https://doi.org/10.1038/onc.2008.272
Abstract
The activating receptor NKG2D (natural-killer group 2, member D) and its ligands play an important role in the NK, γδ+ and CD8+ T-cell-mediated immune response to tumors. Ligands for NKG2D are rarely detectable on the surface of healthy cells and tissues, but are frequently expressed by tumor cell lines and in tumor tissues. It is evident that the expression levels of these ligands on target cells have to be tightly regulated to allow immune cell activation against tumors, but at the same time avoid destruction of healthy tissues. Importantly, it was recently discovered that another safeguard mechanism controlling activation via the receptor NKG2D exists. It was shown that NKG2D signaling is coupled to the IL-15 receptor pathway in a cell-specific manner suggesting that priming of NKG2D-mediated activation depends on the cellular microenvironment and the distinct cellular context. This review will provide a broad overview of our up-to-date knowledge of the NKG2D receptor and its ligands in the context of tumor immunology. Strategies to amplify NKG2D-mediated antitumor responses and counteract tumor immune escape mechanisms will be discussed.Keywords
This publication has 147 references indexed in Scilit:
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous MalignancyImmunity, 2008
- MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myelomaProceedings of the National Academy of Sciences, 2008
- Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virusProceedings of the National Academy of Sciences of the United States of America, 2007
- CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cellsThe Journal of Experimental Medicine, 2007
- Promiscuity and the single receptor: NKG2DNature Reviews Immunology, 2007
- Regulation of ligands for the activating receptor NKG2DImmunology, 2007
- In vivo selection for metastasis promoting genes in the mouseProceedings of the National Academy of Sciences of the United States of America, 2007
- Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15Immunity, 2007
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic functionProceedings of the National Academy of Sciences of the United States of America, 2006